You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2026 › July › 23
Lilly
2 days ago
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
Eli Lilly says it will file for approval of next-generation obesity drug in 2027 as it clears two more trials ⊕⊕
There are now positive results from five late-stage trials on retatrutide, which Lilly is positioning as the next pillar of its obesity portfolio.
page 1 of 1